REG - Savills PLC - Director/PDMR Shareholding

SavillsAnnouncement

03/12/2019 09:40

RNS Number : 4746V
Savills PLC
03 December 2019
 


SAVILLS PLC (THE "COMPANY")
NOTIFICATION OF INTERESTS OF DIRECTORS/ PDMRS AND CONNECTED PERSONS
The Company announces that it has today received notification that Raymond Lee, a PDMR, has purchased 27,544 Savills plc ordinary shares of 2.5p each ("Ordinary Shares") at £9.8157 per share.  As a result, Mr Lee has a total beneficial interest in 105,000 Ordinary Shares, representing 0.073% of the Company's issued share capital.
The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.




1.


Details of the person discharging managerial responsibilities/ person closely associated
 




(a)


Name


Raymond Lee
 




2.


Reason for the notification
 




(a)


Position/ status


CEO, Greater China / PDMR
 




(b)


Initial notification/ Amendment
 


Initial notification




3.


Details of the issuer
 




(a)


Name


Savills plc
 




(b)


LEI


213800WXICGMBWHTA933
 




4.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 




(a)


Description of the Financial Instrument
 


Savills plc Ordinary Shares of 2.5p each




(b)


Identification code of the Financial Instrument
 


GB00B135BJ46




(c)


Nature of the transaction
 


Purchase of Ordinary Shares
 




(d)


Price(s) and volume(s)
 


Price(s)


Volume(s)
 




£9.8157 per share
 


27,544




(e)


Aggregated information
 
-      Aggregated volume
-      Price
 


N/A
 
 




(f)


Date of the transaction
 


2 December 2019




(g)


Place of the transaction
 


London Stock Exchange (XLON)




 
Name of contact and telephone number for queries:
Chris Lee
Group Legal Director & Company Secretary
020 3107 5444
 
3 December 2019 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFMMGZLFVGLZG